Updated July 2026 · 8 min read

Tranexamic Acid (TXA): The ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

TXA is one of the rare drugs that saves lives simply by not letting the clot fall apart. It is cheap, widely available, and time-sensitive in a way most drugs are not — give it early in bleeding and it helps; give it late and the benefit disappears, or worse.

What TXA does

When you bleed, your body forms clot and then, in balance, breaks it down through fibrinolysis. In major hemorrhage that breakdown can run ahead of clot formation, dissolving the very clots holding bleeding in check. TXA blocks plasminogen from converting to plasmin, the enzyme that degrades fibrin. In plain terms: it stabilizes the clot that is already there. It does not create new clotting factors or replace blood — it protects what the patient has managed to form.

The 3-hour window in trauma

The landmark trauma evidence is unusually specific about timing. Given within roughly an hour of injury, TXA meaningfully reduces death from bleeding; given within three hours, it still helps; given after three hours, the signal reverses and mortality can rise. That single fact drives trauma protocols: TXA is a first-hour drug. As the nurse, knowing the injury time and moving quickly on the order is part of the therapy.

Where TXA is used

Trauma. Significant hemorrhage or risk of it, within the 3-hour window — typically a 1 g IV loading dose over 10 minutes followed by 1 g over 8 hours.

Postpartum hemorrhage. A cornerstone alongside uterotonics; earlier administration improves outcomes, commonly 1 g IV with a repeat dose if bleeding continues.

Surgery. Widely used to reduce blood loss and transfusion in cardiac, orthopedic, and other high-blood-loss procedures.

Other bleeding. Used in some GI and mucosal bleeding and in patients with menorrhagia; the role in GI bleeding is more selective.

Dosing at a glance

Administration and cautions

Give the load slowly. Rapid IV push causes hypotension. The loading dose is infused over about 10 minutes, not pushed.

Seizures. TXA lowers the seizure threshold, a risk that climbs with high doses and rapid administration, and is a particular concern in cardiac surgery. Watch for it.

Thrombosis. Because it stabilizes clot, weigh the risk in patients with active thromboembolic disease, DIC, or a strong clotting history. In practice the overall thrombosis rate in trials was reassuring, but it is not a drug to give reflexively to a high-thrombotic-risk patient.

Renal dosing. TXA is renally cleared; doses are reduced in renal impairment to avoid accumulation.

Bottom line

Tranexamic acid is a quietly powerful drug: it doesn't replace blood, it protects the clot the patient already made. Its value is almost entirely front-loaded — start it early in trauma and postpartum hemorrhage, run the loading dose over ten minutes to avoid hypotension, and keep the seizure and thrombosis cautions in mind. Miss the window and you lose the benefit; hit it and TXA is one of the highest-value, lowest-cost interventions in critical care.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.